BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 25156580)

  • 1. Clinical relevance and low tumor-initiating properties of oligometastatic breast cancer in pulmonary metastasectomy.
    Mimoto R; Kobayashi T; Imawari Y; Kamio M; Kato K; Nogi H; Toriumi Y; Hirooka S; Uchida K; Takeyama H
    Breast Cancer Res Treat; 2014 Sep; 147(2):317-24. PubMed ID: 25156580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic factors for recurrent breast cancer patients with an isolated, limited number of lung metastases and implications for pulmonary metastasectomy.
    Yhim HY; Han SW; Oh DY; Han W; Im SA; Kim TY; Kim YT; Noh DY; Chie EK; Ha SW; Park IA; Bang YJ
    Cancer; 2010 Jun; 116(12):2890-901. PubMed ID: 20564396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Possible clinical cure of metastatic breast cancer: lessons from our 30-year experience with oligometastatic breast cancer patients and literature review.
    Kobayashi T; Ichiba T; Sakuyama T; Arakawa Y; Nagasaki E; Aiba K; Nogi H; Kawase K; Takeyama H; Toriumi Y; Uchida K; Kobayashi M; Kanehira C; Suzuki M; Ando N; Natori K; Kuraishi Y
    Breast Cancer; 2012 Jul; 19(3):218-37. PubMed ID: 22532161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-term Survival of Patients with Lung Metastases from Colorectal and Non-colorectal Cancer Who Underwent Pulmonary Metastasectomy.
    Lumachi F; Mazza F; Del Conte A; Lo Re G; Ermani M; Chiara GB; Basso SM
    Anticancer Res; 2015 Jun; 35(6):3563-6. PubMed ID: 26026126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgical approach to pulmonary metastases from breast cancer.
    Kycler W; Laski P
    Breast J; 2012; 18(1):52-7. PubMed ID: 22098366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinicopathologic and prognostic significance of CD44+/CD24(-/low) and CD44-/CD24+ tumor cells in invasive breast carcinomas.
    Mylona E; Giannopoulou I; Fasomytakis E; Nomikos A; Magkou C; Bakarakos P; Nakopoulou L
    Hum Pathol; 2008 Jul; 39(7):1096-102. PubMed ID: 18495204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolonged overall survival after pulmonary metastasectomy in patients with breast cancer.
    Meimarakis G; Rüttinger D; Stemmler J; Crispin A; Weidenhagen R; Angele M; Fertmann J; Hatz RA; Winter H
    Ann Thorac Surg; 2013 Apr; 95(4):1170-80. PubMed ID: 23391172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical detection of breast cancer stem cells in hormone receptor-positive breast cancer and their role in response to endocrine therapy and clinical outcome.
    Hashimoto K; Shimizu C; Tsuda H; Saji S; Osaki A; Shigekawa T; Aogi K
    Oncology; 2012; 82(3):168-74. PubMed ID: 22433454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical features of surgical resection for pulmonary metastasis from breast cancer.
    Chen F; Fujinaga T; Sato K; Sonobe M; Shoji T; Sakai H; Miyahara R; Bando T; Okubo K; Hirata T; Toi M; Date H
    Eur J Surg Oncol; 2009 Apr; 35(4):393-7. PubMed ID: 18562155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of CD44+/CD24-/low cells in breast cancer may not be associated with clinical outcome but may favor distant metastasis.
    Abraham BK; Fritz P; McClellan M; Hauptvogel P; Athelogou M; Brauch H
    Clin Cancer Res; 2005 Feb; 11(3):1154-9. PubMed ID: 15709183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinicopathological significance of CD44+/CD24-/low and CD24+ tumor cells in invasive micropapillary carcinoma of the breast.
    Li W; Liu F; Lei T; Xu X; Liu B; Cui L; Wei J; Guo X; Lang R; Fan Y; Gu F; Tang P; Zhang X; Fu L
    Pathol Res Pract; 2010 Dec; 206(12):828-34. PubMed ID: 20977976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of CD44+CD24- cells on non-sentinel axillary lymph node metastases in sentinel node-positive breast cancer.
    Nogi H; Suzuki M; Kamio M; Kato K; Kawase K; Toriumi Y; Takeyama H; Fukushima H; Morikawa T; Uchida K
    Oncol Rep; 2011 Apr; 25(4):1109-15. PubMed ID: 21308353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of recurrent pulmonary metastases and survival after pulmonary metastasectomy for colorectal cancer.
    Blackmon SH; Stephens EH; Correa AM; Hofstetter W; Kim MP; Mehran RJ; Rice DC; Roth JA; Swisher SG; Walsh GL; Vaporciyan AA
    Ann Thorac Surg; 2012 Dec; 94(6):1802-9. PubMed ID: 23063195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prognosis of pulmonary metastasectomy depends on the location of the primary colorectal cancer.
    Cho JH; Hamaji M; Allen MS; Cassivi SD; Nichols FC; Wigle DA; Shen KR; Deschamps C
    Ann Thorac Surg; 2014 Oct; 98(4):1231-7. PubMed ID: 25086943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary metastases of breast cancer. When is resection indicated?
    Welter S; Jacobs J; Krbek T; Tötsch M; Stamatis G
    Eur J Cardiothorac Surg; 2008 Dec; 34(6):1228-34. PubMed ID: 18824371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is there a role for pulmonary metastasectomy with a curative intent in patients with metastatic urinary transitional cell carcinoma?
    Matsuguma H; Yoshino I; Ito H; Goya T; Matsui Y; Nakajima J; Ikeda N; Okumura S; Shiono S; Nomori H;
    Ann Thorac Surg; 2011 Aug; 92(2):449-53. PubMed ID: 21801905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD44(+)/CD24(-/low) cancer stem/progenitor cells are more abundant in triple-negative invasive breast carcinoma phenotype and are associated with poor outcome.
    Idowu MO; Kmieciak M; Dumur C; Burton RS; Grimes MM; Powers CN; Manjili MH
    Hum Pathol; 2012 Mar; 43(3):364-73. PubMed ID: 21835433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of CD24 and claudin-7 immunoexpression in ductal invasive breast cancer.
    Bernardi MA; Logullo AF; Pasini FS; Nonogaki S; Blumke C; Soares FA; Brentani MM
    Oncol Rep; 2012 Jan; 27(1):28-38. PubMed ID: 21956537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival after lung metastasectomy for colorectal cancer: importance of previous liver metastasis as a prognostic factor.
    Zabaleta J; Aguinagalde B; Fuentes MG; Bazterargui N; Izquierdo JM; Hernández CJ; Enriquez-Navascués JM; Emparanza JI
    Eur J Surg Oncol; 2011 Sep; 37(9):786-90. PubMed ID: 21723689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary metastasectomy secondary to esophageal carcinoma: long-term survival and prognostic factors.
    Kobayashi N; Kohno T; Haruta S; Fujimori S; Shinohara H; Ueno M; Udagawa H
    Ann Surg Oncol; 2014 Jun; 21 Suppl 3():S365-9. PubMed ID: 24796966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.